BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32932265)

  • 61. Mohs Micrographic Surgery Versus Wide Local Excision in the Treatment of Merkel Cell Carcinoma: A Systematic Review.
    Carrasquillo OY; Cancel-Artau KJ; Ramos-Rodriguez AJ; Cruzval-O'Reilly E; Merritt BG
    Dermatol Surg; 2022 Feb; 48(2):176-180. PubMed ID: 34889215
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mohs micrographic surgery for melanoma: A prospective multicenter study.
    Ellison PM; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2019 Sep; 81(3):767-774. PubMed ID: 31150700
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mohs micrographic surgery for fungal soft tissue infections.
    Sachse RE
    Dermatol Surg; 1999 Apr; 25(4):308-10. PubMed ID: 10417588
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mohs micrographic surgery of rare cutaneous tumours.
    Flohil SC; van Lee CB; Beisenherz J; Mureau MAM; Overbeek LIH; Nijsten T; van den Bos RR
    J Eur Acad Dermatol Venereol; 2017 Aug; 31(8):1285-1288. PubMed ID: 27976423
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Treatment of dermatofibrosarcoma of the head and neck with Mohs surgery with paraffin sections.
    González A; Etchichury D; Rivero JM; Adamo L
    J Plast Reconstr Aesthet Surg; 2021 May; 74(5):1061-1070. PubMed ID: 33317985
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mohs micrographic surgery for extramammary Paget disease: a pooled analysis of individual patient data.
    Bae JM; Choi YY; Kim H; Oh BH; Roh MR; Nam K; Chung KY
    J Am Acad Dermatol; 2013 Apr; 68(4):632-637. PubMed ID: 23399462
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The use of Mohs micrographic surgery (MMS) for melanoma in situ (MIS) of the trunk and proximal extremities.
    Stigall LE; Brodland DG; Zitelli JA
    J Am Acad Dermatol; 2016 Nov; 75(5):1015-1021. PubMed ID: 27473456
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Wide excision or Mohs micrographic surgery for the treatment of primary dermatofibrosarcoma protuberans.
    Meguerditchian AN; Wang J; Lema B; Kraybill WG; Zeitouni NC; Kane JM
    Am J Clin Oncol; 2010 Jun; 33(3):300-3. PubMed ID: 19858696
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery.
    Paradisi A; Abeni D; Rusciani A; Cigna E; Wolter M; Scuderi N; Rusciani L; Kaufmann R; Podda M
    Cancer Treat Rev; 2008 Dec; 34(8):728-36. PubMed ID: 18684568
    [TBL] [Abstract][Full Text] [Related]  

  • 70. It's time for Mohs: Micrographic surgery for the treatment of high-risk basal cell carcinomas of the head and neck regions.
    Dika E; Veronesi G; Patrizi A; De Salvo S; Misciali C; Baraldi C; Mussi M; Fabbri E; Tartari F; Lambertini M
    Dermatol Ther; 2020 Jul; 33(4):e13474. PubMed ID: 32391961
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mohs micrographic surgery for eyelid sebaceous carcinoma: A multicenter cohort of 360 patients.
    Zhou C; Wu F; Chai P; Shi Y; Ye J; Shi X; Tan J; Ding Y; Luo Y; Esmaeli B; Jia R; Fan X
    J Am Acad Dermatol; 2019 Jun; 80(6):1608-1617.e1. PubMed ID: 30639290
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mohs micrographic surgery in rare cutaneous tumors: a retrospective study at a Brazilian tertiary university hospital.
    Buffo TH; Stelini RF; Serrano JYM; Pontes LT; Magalhães RF; de Moraes AM
    An Bras Dermatol; 2023; 98(1):36-46. PubMed ID: 36369200
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mohs micrographic surgery and the otolaryngologist.
    Stein JM; Hrabovsky S; Schuller DE; Siegle RJ
    Am J Otolaryngol; 2004; 25(6):385-93. PubMed ID: 15547806
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Low recurrence rate of head and neck basal cell carcinoma treated with Mohs micrographic surgery: A retrospective study of 1021 cases.
    Kuiper EM; van den Berge BA; Spoo JR; Kuiper J; Terra JB
    Clin Otolaryngol; 2018 Oct; 43(5):1321-1327. PubMed ID: 29953746
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identifying and managing those patients at risk for aborted mohs micrographic surgery.
    Zbar RI
    Ann Plast Surg; 2012 Jan; 68(1):67-71. PubMed ID: 21629108
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Tissue-sparing properties of Mohs micrographic surgery for infiltrative basal cell carcinoma.
    van Kester MS; Goeman JJ; Genders RE
    J Am Acad Dermatol; 2019 Jun; 80(6):1700-1703. PubMed ID: 30710602
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Underutilization of Mohs Micrographic Surgery for Less Common Cutaneous Malignancies in the United States.
    Ghareeb ER; Dulmage BO; Vargo JA; Balasubramani GK; Beriwal S
    Dermatol Surg; 2016 May; 42(5):653-62. PubMed ID: 27054447
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mohs micrographic surgery: a cost analysis.
    Cook J; Zitelli JA
    J Am Acad Dermatol; 1998 Nov; 39(5 Pt 1):698-703. PubMed ID: 9810885
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Assessment of intraoperative pain during Mohs micrographic surgery (MMS): An opportunity for improved patient care.
    Connolly KL; Nehal KS; Dusza SW; Rossi AM; Lee EH
    J Am Acad Dermatol; 2016 Sep; 75(3):590-594. PubMed ID: 27125530
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Slow Mohs Micrographic Surgery for Acral Melanoma Treatment in Korean Patients.
    Seo J; Oh Y; Kim SK; Roh MR; Chung KY
    Dermatol Surg; 2021 Feb; 47(2):e42-e46. PubMed ID: 33481431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.